RU2015120376A - Новые антибактериальные соединения и их биологическое применение - Google Patents
Новые антибактериальные соединения и их биологическое применение Download PDFInfo
- Publication number
- RU2015120376A RU2015120376A RU2015120376A RU2015120376A RU2015120376A RU 2015120376 A RU2015120376 A RU 2015120376A RU 2015120376 A RU2015120376 A RU 2015120376A RU 2015120376 A RU2015120376 A RU 2015120376A RU 2015120376 A RU2015120376 A RU 2015120376A
- Authority
- RU
- Russia
- Prior art keywords
- compounds
- formula
- alkyl
- salts
- paragraph
- Prior art date
Links
- 0 CC(C)N(C(*)=C)O Chemical compound CC(C)N(C(*)=C)O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306350.5A EP2725029A1 (en) | 2012-10-29 | 2012-10-29 | New antibacterial compounds and biological applications thereof |
| EP12306350.5 | 2012-10-29 | ||
| PCT/EP2013/072526 WO2014067904A1 (en) | 2012-10-29 | 2013-10-28 | New antibacterial compounds and biological applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015120376A true RU2015120376A (ru) | 2016-12-20 |
Family
ID=47278726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015120376A RU2015120376A (ru) | 2012-10-29 | 2013-10-28 | Новые антибактериальные соединения и их биологическое применение |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9975911B2 (https=) |
| EP (2) | EP2725029A1 (https=) |
| JP (1) | JP6389463B2 (https=) |
| KR (1) | KR20150105300A (https=) |
| CN (1) | CN104936966A (https=) |
| AU (1) | AU2013339557A1 (https=) |
| BR (1) | BR112015009546A2 (https=) |
| CA (1) | CA2889503A1 (https=) |
| CL (1) | CL2015000985A1 (https=) |
| HK (1) | HK1211034A1 (https=) |
| MX (1) | MX2015005498A (https=) |
| RU (1) | RU2015120376A (https=) |
| WO (1) | WO2014067904A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2770537C1 (ru) * | 2021-09-15 | 2022-04-18 | федеральное государственное автономное образовательное учреждение высшего образования «Казанский (Приволжский) федеральный университет» (ФГАОУ ВО КФУ) | Фосфорилсодержащие четвертичные соли аммония с высшими алкильными заместителями, обладающие бактерицидной и фунгицидной активностью |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102282155B (zh) | 2008-12-02 | 2017-06-09 | 日本波涛生命科学公司 | 磷原子修饰的核酸的合成方法 |
| RU2612521C2 (ru) | 2009-07-06 | 2017-03-09 | Онтории, Инк. | Новые пролекарства нуклеиновых кислот и способы их применения |
| JP5868324B2 (ja) | 2010-09-24 | 2016-02-24 | 株式会社Wave Life Sciences Japan | 不斉補助基 |
| CN103796657B (zh) | 2011-07-19 | 2017-07-11 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
| PL2872485T3 (pl) | 2012-07-13 | 2021-05-31 | Wave Life Sciences Ltd. | Asymetryczna grupa pomocnicza |
| BR112016016400A2 (pt) | 2014-01-16 | 2017-10-03 | Wave Life Sciences Ltd | Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos |
| CN108484619A (zh) * | 2018-04-26 | 2018-09-04 | 福建师范大学泉港石化研究院 | 一种罗丹明基Fe3+荧光探针及其制备方法 |
| CN108484620A (zh) * | 2018-04-26 | 2018-09-04 | 福建师范大学泉港石化研究院 | 一种水溶性罗丹明基Cu2+荧光探针及其合成方法 |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| SG11202101255UA (en) | 2018-08-09 | 2021-03-30 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| CN116905145B (zh) * | 2023-08-07 | 2026-03-06 | 安徽恒益智能科技股份有限公司 | 一种抗菌包芯纱线及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206156A (en) * | 1976-07-27 | 1980-06-03 | Fujisawa Pharmaceutical Company, Limited | Hydroxyaminohydrocarbonphosphonic acids |
| GB1580899A (en) | 1976-07-27 | 1980-12-10 | Fujisawa Pharmaceutical Co | Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof |
| JPS5463024A (en) * | 1977-10-27 | 1979-05-21 | Fujisawa Pharmaceut Co Ltd | 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use |
| JPS5562019A (en) * | 1978-09-14 | 1980-05-10 | Fujisawa Pharmaceut Co Ltd | Antibacterial |
| US4693742A (en) | 1983-12-20 | 1987-09-15 | Rohm And Hass Company | Herbicidal hydroxyamino phosphonic acids and derivatives |
| CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| US6949528B1 (en) | 1998-03-18 | 2005-09-27 | Goddard John G | Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| BR9912062A (pt) * | 1998-07-15 | 2001-04-03 | Hassan Jomaa | Compostos orgânicos fosforosos e seu uso |
| US6911450B1 (en) | 2001-01-29 | 2005-06-28 | Universite De Geneve | Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| FR2872158B1 (fr) | 2004-06-28 | 2006-11-03 | Merck Sante Soc Par Actions Si | Nouveaux composes diazeniumdiolates, leur procede de preparation et leur utilisation therapeutique |
| EP1669365A1 (en) | 2004-12-03 | 2006-06-14 | Mutabilis SA | Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases |
| WO2008033747A2 (en) | 2006-09-11 | 2008-03-20 | Curis, Inc. | Multi-functional small molecules as anti-proliferative agents |
| AU2007301607A1 (en) | 2006-09-25 | 2008-04-03 | Mutabilis Sa | Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| EP2141164A1 (en) | 2008-07-01 | 2010-01-06 | Mutabilis | New 1,2,4-triazine derivatives and biological applications thereof |
| HRP20150778T1 (hr) * | 2009-01-23 | 2015-08-28 | Euro-Celtique S.A. | Derivati hidroksamske kiseline |
| WO2011045703A2 (en) | 2009-10-13 | 2011-04-21 | Pfizer Inc. | C-linked hydroxamic acid derivatives useful as antibacterial agents |
| EP2377853A1 (en) | 2010-04-09 | 2011-10-19 | Universite de Rouen | 7,11-Methanocycloocta[b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| EP2646451A2 (en) | 2010-12-01 | 2013-10-09 | Laboratoire Biodim | Heptose derivatives for use in the treatment of bacterial infections |
| US9593136B2 (en) * | 2011-07-01 | 2017-03-14 | The George Washington University | Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase |
-
2012
- 2012-10-29 EP EP12306350.5A patent/EP2725029A1/en not_active Withdrawn
-
2013
- 2013-04-28 BR BR112015009546A patent/BR112015009546A2/pt not_active IP Right Cessation
- 2013-10-28 CA CA2889503A patent/CA2889503A1/en not_active Abandoned
- 2013-10-28 JP JP2015538485A patent/JP6389463B2/ja not_active Expired - Fee Related
- 2013-10-28 AU AU2013339557A patent/AU2013339557A1/en not_active Abandoned
- 2013-10-28 CN CN201380064824.9A patent/CN104936966A/zh active Pending
- 2013-10-28 HK HK15111841.1A patent/HK1211034A1/xx unknown
- 2013-10-28 US US14/438,929 patent/US9975911B2/en active Active - Reinstated
- 2013-10-28 MX MX2015005498A patent/MX2015005498A/es unknown
- 2013-10-28 WO PCT/EP2013/072526 patent/WO2014067904A1/en not_active Ceased
- 2013-10-28 KR KR1020157014444A patent/KR20150105300A/ko not_active Withdrawn
- 2013-10-28 EP EP13783572.4A patent/EP2912043B1/en not_active Not-in-force
- 2013-10-28 RU RU2015120376A patent/RU2015120376A/ru unknown
-
2015
- 2015-04-17 CL CL2015000985A patent/CL2015000985A1/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2770537C1 (ru) * | 2021-09-15 | 2022-04-18 | федеральное государственное автономное образовательное учреждение высшего образования «Казанский (Приволжский) федеральный университет» (ФГАОУ ВО КФУ) | Фосфорилсодержащие четвертичные соли аммония с высшими алкильными заместителями, обладающие бактерицидной и фунгицидной активностью |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014067904A1 (en) | 2014-05-08 |
| EP2912043B1 (en) | 2016-11-30 |
| KR20150105300A (ko) | 2015-09-16 |
| AU2013339557A1 (en) | 2015-04-30 |
| MX2015005498A (es) | 2016-01-08 |
| EP2912043A1 (en) | 2015-09-02 |
| US20150291636A1 (en) | 2015-10-15 |
| HK1211034A1 (en) | 2016-05-13 |
| US9975911B2 (en) | 2018-05-22 |
| JP2015536928A (ja) | 2015-12-24 |
| BR112015009546A2 (pt) | 2017-07-04 |
| JP6389463B2 (ja) | 2018-09-12 |
| EP2725029A1 (en) | 2014-04-30 |
| CA2889503A1 (en) | 2014-05-08 |
| CN104936966A (zh) | 2015-09-23 |
| CL2015000985A1 (es) | 2016-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015120376A (ru) | Новые антибактериальные соединения и их биологическое применение | |
| ES2558685T3 (es) | Uso de compuestos de pirroloquinolina para eliminar microorganismos clínicamente latentes | |
| JP2015536928A5 (https=) | ||
| EA200901277A1 (ru) | Фармацевтические составы, содержащие пропиленгликольгидрат дапаглифлозина | |
| UY39032A (es) | Compuestos heterocíclicos como agentes antivirales | |
| BRPI0514691A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
| BR0212458A (pt) | Composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, composição farmacêutica, e, processo para a preparação de um composto ou sais farmaceuticamente aceitável, ou ésteres hidrolizáveis in vivo deste | |
| UY28578A1 (es) | Derivados de amida | |
| CA2870335A1 (en) | Enhanced anti-influenza agents conjugated with anti-inflammatory activity | |
| RU2012117829A (ru) | Фосфорамидатные производные нуклеозидов | |
| CY1113269T1 (el) | Παραγωγα ινδαζολυλ αμιδιου για τη θεραπευτικη αγωγη διαταραχων διαμεσολαβουμενων υπο υποδοχεα γλυκοκορτικοειδων | |
| TW200745111A (en) | New compounds | |
| AR070299A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas, usos y composiciones farmaceuticas | |
| BR112013013950A2 (pt) | antagonista de lpa1 policíclico e usos dos mesmos | |
| RU2008145714A (ru) | Пуриновые производные в качестве активатора аденозинового рецептора | |
| JP2013519653A5 (https=) | ||
| RU2007130802A (ru) | Пуриновые производные в качестве агонистов рецептора а2а | |
| EA022994B1 (ru) | Способ подавления толерантности к опиоидному анальгетику | |
| EP4635494A3 (en) | AMIDO HETERO-ROMATIC COMPOUNDS | |
| CY1111574T1 (el) | Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων | |
| MX2011012544A (es) | Oxazolidinona que contiene compuestos de dimero, composiciones y metodos para elaborar y usar. | |
| AR050956A1 (es) | Derivados de bencimidazol; sintesis de los mismos; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por ligandos del receptor cb1. | |
| NZ548689A (en) | Antiparasitic composition containing an organic amine salt of closantel | |
| AR113980A1 (es) | Método para mejorar la biodisponibilidad oral de una droga | |
| WO2025132358A1 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of infectious diseases |